Measuring Skin Elasticity in Lymphedema Patients

Last updated: June 2, 2025
Sponsor: Beth Israel Deaconess Medical Center
Overall Status: Terminated

Phase

N/A

Condition

Lymphedema

Treatment

Lymphedema Indentometer

Clinical Study ID

NCT03313999
2024P000442
  • Ages > 18
  • All Genders

Study Summary

This protocol will utilize the lymphedema indentometer, or durometer (a novel, noninvasive piece of equipment that measures skin elasticity), to better characterize disease progression in patients with lymphedema. Beth Israel Deaconess Medical Center patients who undergo treatment of lymphedema will be candidates for this noninvasive test. This device and the data it generates will help understand the incidence of lymphedema at Beth Israel Deaconess Medical Center compared to national data and the outcomes of surgical treatment of lymphedema.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients evaluated by the Beth Israel Deaconess Medical Center Lymphedema team witha diagnosis of lymphedema OR determined to be at risk of developing Lymphedema inany of their extremities

  • Patients must be over 18 years of age

  • Patients must be willing and capable to provide informed consent

  • Patients must speak English

Exclusion

Exclusion Criteria:

  • None

Study Design

Total Participants: 7
Treatment Group(s): 1
Primary Treatment: Lymphedema Indentometer
Phase:
Study Start date:
February 18, 2018
Estimated Completion Date:
June 02, 2025

Connect with a study center

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts 02215
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.